Skip to main content
. 2019 Jun 18;10(40):4026–4037. doi: 10.18632/oncotarget.26999

Table 2. Shows clinical variables of 318 cases of pancreatic cystic lesions.

Clinical variable Pancreatic cystic lesions (n = 318) Case Distribution: M = mucinous PCN NM = non-mucinous PCL
Cytology diagnoses:
(n of 309, %)
Non-diagnostic “ND” (89/309, 28.8%) M=45 (51%), NM=44 (49%) (p = 1.000)
Negative “NEG” (156/309, 50.5%) M=38 (24%), NM=118 (76%) (p = 0.0001)
Atypical/suspicious “ATY/SUS” (53/309, 17.2%) M=53 (100%), NM=0 (0%) (p = 0.0001)
Positive “ POS” (11/309, 3.6%) M=11 (100%), NM=0 (0%) (p = 0.0001)
Female : male 162 : 156 (1.04) M=0.87, NM=1.19 (p = 0.18)
Patient Age (year), Median (range) 61.5, (15 – 93) M=66.8, NM=56.7 (p = 0.0001)
CEA fluid concentration (ng/ml) Median (range) 1056.5, (0.1 – 11000) M=2126.7, NM=188.9 (p = 0.0001)
Cyst size (mm) Median (range) 33.6, (5 – 114) M=30.2, NM=36.6 (p = 0.015)
Amylase fluid concentration (u/L), Median (range) 6650.3, (2.4 – 24990) M=5061.8, NM=7764.6 (p = 0.008)
Cyst fluid viscosity (n = 275) Viscous (V)=127 Non-viscous (NV)=148 V, M=91, NM=36 (p = 0.0001) NV, M=35, NM=113

The univariate analysis is performed between different characteristics in mucinous (M) and non-mucinous (NM) cases primarily classified by the proposed algorithm. Statistically significant differences are shown in bold.